Skip to main content
. 2023 Jul 26;14:1188452. doi: 10.3389/fpsyt.2023.1188452

Table 3.

Relationships between fatty acid levels and clinical/cognitive indices.

PANSS total PANSS positive PANSS negative PANSS general psychopathology BACS SCoRS SOFAS
ARMS FES ARMS FES ARMS FES ARMS FES ARMS FES ARMS FES ARMS FES
Saturated PA 0.18 0.05 0.03 −0.01 0.22 0.25 0.14 −0.16 0.02 −0.03 −0.14 0.20 −0.03 −0.64
SA −0.14 −0.46 −0.13 −0.58 −0.14 −0.37 −0.05 −0.34 −0.19 0.26 0.23 −0.13 −0.16 0.06
n-9 monounsaturated OA −0.12 0.71* −0.07 0.25 −0.10 0.63 −0.17 0.61 0.11 −0.60 0.11 0.08 −0.06 −0.14
NA 0.43* 0.17 0.19 −0.27 0.36* 0.13 0.36* 0.33 −0.05 −0.17 −0.17 −0.09 0.20 0.19
n-3 polyunsaturated EPA 0.04 −0.17 0.11 0.15 0.09 −0.18 −0.04 −0.17 0.03 −0.05 −0.22 0.12 0.25 −0.20
DPA 0.12 0.03 0.18 −0.14 0.13 0.01 0.05 0.17 0.13 −0.39 −0.10 −0.20 0.08 0.25
DHA 0.20 0.01 0.14 0.10 0.18 −0.05 0.15 0.15 0.02 −0.29 −0.20 0.27 0.24 0.21
n-6 polyunsaturated LA −0.19 0.04 −0.05 0.54 −0.22 −0.28 −0.17 0.16 0.01 0.15 0.11 −0.27 −0.10 0.55
DGLA 0.08 0.07 0.09 0.38 0.00 −0.11 0.07 0.13 −0.21 −0.04 0.10 −0.14 −0.13 0.43
AA −0.05 −0.21 −0.04 −0.40 −0.04 −0.16 0.00 −0.18 0.03 0.19 −0.07 −0.03 −0.08 −0.23
summary value n-3 total 0.18 −0.08 0.17 −0.09 0.18 −0.06 0.11 0.07 0.04 −0.32 −0.22 0.22 0.25 0.25
n-6 total −0.17 −0.07 −0.03 0.29 −0.23 −0.30 −0.09 −0.02 −0.04 0.54 0.12 −0.38 −0.24 0.13
n-6/n-3 ratioa −0.16 −0.10 −0.13 −0.27 −0.16 −0.05 −0.09 −0.12 −0.02 0.29 0.18 −0.29 −0.22 −0.13
omega-3 indexb 0.17 −0.01 0.15 0.06 0.18 −0.01 0.11 0.09 0.01 −0.26 −0.22 0.33 0.25 0.10

Values are Spearman’s rho, calculated using semi-partial correlation analysis that only fatty acid indices were controlled by age as a covariate. *False discovery rate adjustment p value < 0.1 (written in bold letters). There was a significant correlation between fatty acid composition and clinical/cognitive indices, however, they did not survive after post-hoc analysis for multiple comparison. AA, arachidonic acid (20:4 n-6); ARMS, at-risk mental state; BACS, brief assessment of cognition in schizophrenia; DGLA, dihomogammalinolenic acid (20:3 n-6); DHA, docosahexaenoic acid (22:6 n-3); DPA, docosapentaenoic acid (22:5 n-3); EPA, eicosapentaenoic acid (20:5 n-3); FES, first-episode schizophrenia; H, healthy control; LA, linoleic acid (18:2 n-6); NA, nervonic acid (24:1 n-9); OA, oleic acid (18:1 n-9); PA, palmitic acid (16:0); PANSS, positive and negative syndrome scale; SA, stearic acid (18:0); SCoRS, schizophrenia cognition rating scale; SOFAS, social and occupational functioning assessment scale.

a

n-6/n-3 ratio = AA/(EPA + DHA).

b

omega-3 index = EPA + DHA.